Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.2750 (-0.89%) ($7.2750 - $7.2750) on Wed. Feb. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.64% (three month average) | RSI | 46 | Latest Price | $7.2750(-0.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(50%) IBB(37%) IWC(29%) ARKG(28%) IWO(27%) | Factors Impacting IOVA price | IOVA will decline at least -2.32% in a week (0% probabilities). VIXM(-14%) BND(-11%) UUP(-9%) XLP(-8%) USO(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.32% (StdDev 4.64%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.58 | 5 Day Moving Average | $7.32(-0.61%) | 10 Day Moving Average | $7.68(-5.27%) | 20 Day Moving Average | $7.58(-4.02%) | To recent high | -11.7% | To recent low | 29.7% | Market Cap | $1.065b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |